"Normetanephrine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A methylated metabolite of norepinephrine that is excreted in the urine and found in certain tissues. It is a marker for tumors.
Descriptor ID |
D009647
|
MeSH Number(s) |
D02.033.100.291.502.651 D02.092.063.480.651 D02.092.211.215.311.560.651 D02.092.311.461.651 D23.101.140.540
|
Concept/Terms |
Normetanephrine- Normetanephrine
- Normetadrenaline
- 3-Methoxynoradrenaline
- 3 Methoxynoradrenaline
|
Below are MeSH descriptors whose meaning is more general than "Normetanephrine".
Below are MeSH descriptors whose meaning is more specific than "Normetanephrine".
This graph shows the total number of publications written about "Normetanephrine" by people in this website by year, and whether "Normetanephrine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2015 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Normetanephrine" by people in Profiles.
-
Refractory Hypertension: Evidence of Heightened Sympathetic Activity as a Cause of Antihypertensive Treatment Failure. Hypertension. 2015 Jul; 66(1):126-33.
-
Effect of fluvoxamine, imipramine and placebo on catecholamine function in depressed outpatients. J Psychiatr Res. 1993 Apr-Jun; 27(2):161-72.
-
Indices of noradrenergic output in depression. Psychiatry Res. 1986 Sep; 19(1):59-73.
-
Relationships between urinary catecholamine metabolites, particularly MHPG, and selected personality and physical fitness characteristics in normal subjects. Psychosom Med. 1984 Nov-Dec; 46(6):523-33.
-
Influence of catecholamine activity on the hierarchical relationships among physical fitness condition and selected personality characteristics. J Clin Psychol. 1984 Nov; 40(6):1308-17.